Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
10.27
-0.52 (-4.82%)
At close: Aug 28, 2026, 4:00 PM EDT
10.50
+0.23 (2.24%)
After-hours: Aug 28, 2026, 7:48 PM EDT

Olema Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
48.648.3139.4868.5423.713.81
Short-Term Investments
412.47457.14294.61193.27180.72273.44
Cash & Short-Term Investments
461.07505.44434.09261.81204.42287.25
Cash Growth
27.40%16.44%65.80%28.07%-28.84%-15.15%
Other Receivables
3.174.062.120.670.320.13
Receivables
3.174.062.120.670.320.13
Prepaid Expenses
5.644.371.92.352.642.97
Other Current Assets
-1.590.371.681.520.33
Total Current Assets
469.88515.45438.47266.51208.9290.69
Property, Plant & Equipment
1.021.422.063.262.54.72
Long-Term Deferred Charges
-0.890.68---
Other Long-Term Assets
14.915.679.767.174.250.54
Total Assets
486.58533.43450.98276.95215.65295.95

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.679.254.462.70.370.02
Accrued Expenses
50.6741.4336.1317.8615.097.81
Current Portion of Leases
0.661.121.170.991.020.93
Current Income Taxes Payable
0.02--0.070.070.09
Other Current Liabilities
-----0.17
Total Current Liabilities
53.0151.841.7621.6216.559.02
Long-Term Debt
33----
Long-Term Leases
-0.070.261.431.552.36
Total Liabilities
56.0154.8742.0223.0518.111.38

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01000
Additional Paid-In Capital
1,1451,075843.92559.18408.33388.9
Retained Earnings
-713.85-597.56-435.11-305.63-208.98-104.19
Comprehensive Income & Other
-0.950.620.140.35-1.81-0.15
Total Common Equity
430.56478.56408.96253.9197.55284.57
Shareholders' Equity
430.56478.56408.96253.9197.55284.57
Total Liabilities & Equity
486.58533.43450.98276.95215.65295.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.664.191.432.422.573.29
Net Cash (Debt)
457.41501.24432.66259.39201.86283.96
Net Cash Growth
28.07%15.85%66.80%28.50%-28.91%-16.12%
Net Cash Per Share
4.765.767.375.735.057.18
Filing Date Shares Outstanding
87.587.1668.3355.9140.6339.85
Total Common Shares Outstanding
87.4581.3874.3154.9940.2939.84
Working Capital
416.86463.65396.72244.89192.35281.67
Book Value Per Share
4.925.885.504.624.907.14
Tangible Book Value
429.78478.56408.96253.9197.55284.57
Tangible Book Value Per Share
4.915.885.504.624.907.14
Machinery
-----1.7
SEC Filings: 10-K · 10-Q